halo landing

Article

One click can help millions around the world. Every new healthcare professional who creates a free account on www.cancernetwork.com will trigger our donation of $10 to the international organization Doctors Without Borders/ Mdecins Sans Frontires (MSF) - a non-profit delivering emergency medical assistance in nearly 60 countries to people affected by armed conflict, epidemics, malnutrition, natural disasters, or exclusion from health care. It's our way of promoting global social good for doctors caring for those in desperate need. Our goal is to donate $25,000 - enough for vaccinations for 25,000 people against meningitis, measles, polio or other deadly epidemics.

Imagine that you could
improve the lives of millions
with just a click of a mouse.

You can. And it costs you nothing.

One click can help millions around the world. Every new healthcare professional who creates a free account on www.cancernetwork.com will trigger our donation of $10 to the international organization Doctors Without Borders/ Mdecins Sans Frontires (MSF) - a non-profit delivering emergency medical assistance in nearly 60 countries to people affected by armed conflict, epidemics, malnutrition, natural disasters, or exclusion from health care. It's our way of promoting global social good for doctors caring for those in desperate need. Our goal is to donate $25,000 - enough for vaccinations for 25,000 people against meningitis, measles, polio or other deadly epidemics.

One click improves the care of patients in our local communities.
As a leader in providing highly respected and valued content and services to health care professionals in this country, we provide free content that helps medical practitioners like you become better, more effective and knowledgeable in the latest discoveries. In addition to our donation, your click will grant you access to free, timely content from cancernetwork.com to help keep you on the cutting edge of cancer care.

One click starts the movement - together we can help save lives.

 

Thank you for spreading the word!

 

 

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.